Oxurion NV (GB:0G99) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oxurion NV, a Belgian biopharmaceutical company, has announced the successful completion of a reverse share split, resulting in a new total of 1,336,265 ordinary shares, which will be used as the denominator for shareholder percentage calculations. The company, listed on Euronext Brussels and specializing in ophthalmic therapies, has also issued updated voting rights and share capital information post-split.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
